BioStem Technologies, Inc.
BSEM
$14.69
$0.1621.12%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 30.25% | 16.56% | 262.03% | -70.94% | 42.50% |
| Total Depreciation and Amortization | 95.09% | -5.21% | -1.65% | -2.50% | -7.89% |
| Total Amortization of Deferred Charges | 491.12% | -19.06% | -80.76% | 226.72% | -- |
| Total Other Non-Cash Items | -150.03% | 44.24% | 78.12% | 31.86% | -25.90% |
| Change in Net Operating Assets | 231.08% | 49.19% | -890.95% | -152.15% | -64.46% |
| Cash from Operations | 50.09% | 1,029.08% | 139.55% | -261.01% | 61.71% |
| Capital Expenditure | 23.25% | -1,190.32% | -- | 100.00% | -289.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -758.00% | -1,190.32% | -- | 100.00% | -288.45% |
| Total Debt Issued | -- | -- | -- | -87.53% | -54.74% |
| Total Debt Repaid | 32.47% | 45.76% | 13.93% | -59.38% | -189.36% |
| Issuance of Common Stock | -- | -100.00% | -87.08% | 2,644.68% | -57.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 79.53% | -49.86% | -109.20% | 463.57% | -76.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.63% | 1,368.28% | 211.81% | 160.54% | -222.16% |